An Already Highly competitive funding environment is becoming even tougher for CME providers. Facing decreasing budgets and increasing regulatory scrutiny, commercial supporters are becoming much more discriminating about approving grants. “Five years ago we approved 70 percent of the grant applications we received; that figure dropped to 26 percent in 2008,” said Christine Beebe, MS, associate director, medical affairs, Takeda Pharmaceuticals, Deerfield, Ill. Speaking during a ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.